Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | ATR | Q13535 | 1/20 | 0.36 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2832964 | 0.86 | GRM5 (0.52) | GRM5CYP1A2CYP2C9KCNH2JAK2 | |
| SCHEMBL2830193 | 0.85 | GRM5 (0.51) | GRM5CYP1A2CYP2C9KCNH2JAK2 | |
| SCHEMBL2830236 | 0.85 | GRM5 (0.71) | GRM5JAK2 | |
| SCHEMBL2826336 | 0.83 | GRM5 (0.70) | GRM5CYP1A2CYP2C9KCNH2CYP3A4 | |
| SCHEMBL15663522 | 0.82 | GRM5 (0.40) | GRM5CYP1A2CYP2C9KCNH2CYP3A4 | |
| SCHEMBL2826581 | 0.82 | GRM5 (0.50) | GRM5JAK2 | |
| SCHEMBL2829131 | 0.82 | GRM5 (0.47) | GRM5CYP1A2CYP2C9KCNH2JAK2 | |
| SCHEMBL2832204 | 0.82 | GRM5 (0.56) | GRM5CYP1A2CYP2C9KCNH2JAK2 | |
| SCHEMBL2829440 | 0.81 | GRM5 (0.51) | GRM5CYP1A2CYP2C9KCNH2CYP3A4 | |
| SCHEMBL2832138 | 0.81 | GRM5 (0.56) | GRM5CYP1A2CYP2C9KCNH2JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1844044-B1 | THIAZOLE-4-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2010-07-21 | — | — | EP | claimed |